Vaccines
RSSArticles
-
Analysts Suggest U.S. COVID-19 Vaccination Program Prevented Millions of Hospitalizations, Deaths
The pandemic has taken a heavy toll, but the damage could be so much worse without vaccines.
-
Pandemic Emergency Funds Spiked Healthcare Spending
Data show eye-popping healthcare expenditure growth for 2020, driven by federal paycheck protection, provider assistance, vaccine development, and virus testing.
-
Infectious Disease Alert Updates
Candida auris Outbreak in Southern California; Healthcare Worker Vaccine Mandates
-
Looking Back, COVID-19 Vaccination Woes Were Predictable
Efficacy, protection duration, side effects, and FDA approval factored into decisions about choosing a COVID-19 vaccine.
-
How an Influenza Vaccine Can Affect Cardiovascular Disease
A randomized, controlled trial of influenza vaccine vs. placebo in patients with acute myocardial infarction or at high risk for coronary artery disease inoculated during the index hospitalization showed a lower risk of the combined endpoint of death, myocardial infarction, or stent thrombosis at one year.
-
COVID-19 Vaccination, Pregnancy, Lactation, and Fertility
Vaccination rates are notably low among pregnant women. Clinicians should underscore the safety of vaccination and the risks of natural infection, particularly in pregnancy and in patients with underlying comorbidities.
-
Homelessness and COVID-19
Extra screening in care for homeless persons can help solve many problems, including the administration of COVID-19 vaccination to this vulnerable population.
-
Regulators Sign Off on COVID-19 Vaccine ‘Mix and Match’
Federal agencies expand, clarify guidance on booster shots.
-
Adjuvanted Zoster Vaccine: Persistent Protection
The adjuvanted recombinant zoster vaccine efficacy is high and persistent, with apparent plateauing at > 84% four to six years after vaccination.
-
COVID-19 Vaccine mRNA Injection (Comirnaty)
Comirnaty is the first COVID-19 vaccine to receive full FDA approval.